Black-Market Peptides Fuel a Multibillion-Dollar Gold Rush

Bloomberg's Madison Muller and Amanda Mull break down a rising black-market trend in the 'wellness' space, as customers look for more shots to fix issues like sleep or weight following the success of GLP-1s. However, Muller says that the drugs carry a risk, whether it's using a non FDA tested substance or user error around the injection itself.